Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

LUSEDRA

FOSPROPOFOL DISODIUM

Standard Dose
1050MG/30ML (35MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview LUSEDRA is listed in Drugs@FDA under application 022244 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient FOSPROPOFOL DISODIUM Form and strength SOLUTION;INTRAVENOUS - 1050MG/30ML (35MG/ML) Sponsor EISAI INC Submission history Latest submission status date: 2008-12-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview LUSEDRA is listed in Drugs@FDA under application 022244 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient FOSPROPOFOL DISODIUM Form and strength SOLUTION;INTRAVENOUS - 1050MG/30ML (35MG/ML) Sponsor EISAI INC Submission history Latest submission status date: 2008-12-08 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.